163 related articles for article (PubMed ID: 33285246)
1. siRNA delivery to macrophages using aspherical, nanostructured microparticles as delivery system for pulmonary administration.
Fischer T; Tschernig T; Drews F; Brix K; Meier C; Simon M; Kautenburger R; Schneider M
Eur J Pharm Biopharm; 2021 Jan; 158():284-293. PubMed ID: 33285246
[TBL] [Abstract][Full Text] [Related]
2. Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA.
Fischer T; Winter I; Drumm R; Schneider M
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34200405
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
5. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery.
Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S
Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages.
Kelly C; Yadav AB; Lawlor C; Nolan K; O'Dwyer J; Greene CM; McElvaney NG; Sivadas N; Ramsey JM; Cryan SA
Mol Pharm; 2014 Nov; 11(11):4270-9. PubMed ID: 25243784
[TBL] [Abstract][Full Text] [Related]
7. Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery.
Kasten G; Silva LF; Lemos-Senna E
Drug Dev Ind Pharm; 2016 May; 42(5):776-787. PubMed ID: 26266961
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
[No Abstract] [Full Text] [Related]
9. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
10. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
11. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
12. Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo.
Lee S; Yang SC; Kao CY; Pierce RH; Murthy N
Nucleic Acids Res; 2009 Dec; 37(22):e145. PubMed ID: 19783825
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles for local delivery of siRNA in lung therapy.
Kubczak M; Michlewska S; Bryszewska M; Aigner A; Ionov M
Adv Drug Deliv Rev; 2021 Dec; 179():114038. PubMed ID: 34742826
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive solid lipid microparticles for controlled release of a corticosteroid in the chronic obstructive pulmonary disease treatment.
Amore E; Ferraro M; Manca ML; Gjomarkaj M; Giammona G; Pace E; Bondì ML
Nanomedicine (Lond); 2017 Oct; 12(19):2287-2302. PubMed ID: 28868971
[TBL] [Abstract][Full Text] [Related]
16. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.
Wanakule P; Liu GW; Fleury AT; Roy K
J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
[TBL] [Abstract][Full Text] [Related]
18. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose.
Zhang L; Yang L; Zhang X; Jiaqi L; Fan L; Beck-Broichsitter M; Zhang X; Muenster U; Wang X; Zhao J; Zhang Y; Mao S
J Control Release; 2018 Aug; 283():163-174. PubMed ID: 29842919
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
[TBL] [Abstract][Full Text] [Related]
20. Carrier free indomethacin microparticles for dry powder inhalation.
Ceschan NE; Bucalá V; Mateos MV; Smyth HDC; Ramírez-Rigo MV
Int J Pharm; 2018 Oct; 549(1-2):169-178. PubMed ID: 30071308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
